ASCO Power Technologies announces that SourcePacT™, the first Source Isolation Switch to enable Battery Energy Storage Systems (BESS) to provide emergency power to critical loads, is now the first ...

In amongst the big clinical trial readouts at ASCO, a new research project made ... omics’, which combines gene sequencing with imaging technologies to analyse RNA and proteins not just for ...

ASCO has signed a letter of intent with Windeed, aimed at strengthening the companies’ positions in the floating offshore ...

FDA approves first-of-its-kind new ‘bubble’ treatment for liver cancer - Histotripsy could cause less harmful side effects ...

Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025 ...

Two impressive studies in lung cancer and another in breast cancer made Sunday a stellar day for AstraZeneca at the ASCO congress. Three of the group’s top cancer drugs were on display – EGFR ...

FORT MYERS, Fla., Oct. 1, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to ...

A new study released to coincide with World Cancer Research Day today argues that wider access to clinical trials of new ...

2024--Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi’s RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors SAN DIEGO, June 03, 2024--Calidi ...

The findings, presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago on Sunday 2 June, involved analysing blood samples from the ChemoNEAR sample collection study for ...

As we enter a critical phase in our company’s journey, Mainz Biomed’s vision remains focused on leading the way in cancer diagnostics,” said Guido Baechler, CEO of Mainz Biomed. “Our groundbreaking ...